Navigation Links
Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts

NEW YORK, Aug. 1, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require frequent drug administration for a protracted period of time. While several approaches for delivering active substances to, and systematically via, the lungs compete in this space, recent advances and investment in powder formulations, particle engineering, and device architecture have positioned dry powder inhalation (DPI) as a formidable challenger to more established pulmonary methods such as metered dose inhalers and nebulizers. While evolving DPI technology and combination therapeutic products continue to have a significant impact on the treatment of upper respiratory diseases and conditions, dry powder inhalers are making strides in applications requiring the systemic delivery of both small and large molecule and engineered macromolecules for the treatment of a range of pathologies.


• Analyzes and evaluates Dry Powder Inhalers and competing inhaled drug delivery technologies and assesses the market potential for existing and probable future products

• Examines Dry Powder Inhaler design issues and evolving market factors

• Forecasts the impact of DPI technology and devices on drug delivery markets and projects probable future developments

• Provides forecasts of DPI combination product demand by indication and drug class to 2014

• Profiles Dry Powder Inhalation market participants, their technology, product development activity, and business strategies

Executive Summary

The Market Picture for Inhaled Therapeutics

Devices, Formulations and Market Evolution

Established Therapeutic Targets

Emerging Therapies

Demographics and Growth

Competing Technologies

Market Drivers

Risk Factors

Dry Powder Inhalation Technology

Dry Powder Formulations

Dry Powder Particle Technology & Powder Engineering

Dry Powder Formulations

Dry Powder Processing

Dry Powder Packaging

Emerging Formulations

Dry Powder Inhalers

DPI Device Characteristics

DPI Design Parameters

DPI Device Assessments

Acu-Breathe (Respirics)

Aerolizer Novartis)

AIR (Civitas/Alkermes)

Airmax (Teva)

Aspirair (Vectura)

Axahaler (S.M.B.)

Breezhaler (Novartis)

Clickhaler (Vectura)

Conix Dry (3M)

Cricket (Mannkind)

Cyclohaler (Teva)

Diskhaler (GlaxoSmithKline)

Diskus (GlaxoSmithKline)

Dreamboat (Mannkind)

Easyhaler (Orion)

EZ Aer (Aerovance)

Flexhaler (AstraZeneca)

Genuair (Almirall)

Gemini (GSK)

Handihaler Boehringer Ingelheim)

MicroDose (MicroDose Therapeutx)

Next DPI (Chiesi)

Novolizer (Meda)

Oximax (Mantecorp)

Podhaler (Novartis)

Pulmojet (sanofi-aventis)

Pulvinal (Chiesi)

Skyehaler (SKyepharma)

Solis (Sandoz/Novartis)

Taifun (Akela)

Taper Dry (3M)

Trivair (Trimel Bipharma)

Twincaps/Flowcaps (Hovione)

Twisthaler (Schering /Merck)

Turbuhaler (AstraZeneca)

Dry Powder Inhalation – Therapeutic Segment Analysis & Forecasts

Upper Respiratory Indications

Disease Segments

Therapeutic Landscape

Prescribing Trends and Growth Factors

Systemic Drug Delivery



Hereditary Diseases

Cystic Fibrosis

Infectious Diseases



Pain Management

Market Factors

Device Design

Regulatory Issues

Patient Compliance

The Role of CMOs/CSOs

Healthcare Economics

Company Profiles

To order this report:

Drug Delivery Technology Industry: Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts

Drug Delivery Technology Business News

More  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Data Show Aerovances Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients
3. ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
4. New Powder Speeds Healing of Difficult Foot Wounds
5. Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lees Pharmaceuticals
6. FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
7. Hoviones TwinCaps(R) Dry-powder Inhaler Approved in Japan as Part of Inavir(R) Influenza Treatment
8. FDA Approves Pharmaxis ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
9. Reportlinker Adds Dry Powder Inhalation
10. Pharmaxis Launches ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
11. RSB Spine, LLC, Announces Distribution Agreement with Paradigm BioDevices, Inc.
Post Your Comments:
(Date:10/13/2015)... Calif. , Oct. 13, 2015  SRI ... up to $100 million over five years by ... (NIAID), part of the National Institutes of Health, ... treat acute or delayed effects of radiation exposure. ... a division of SRI International will provide services, ...
(Date:10/13/2015)... , Oct. 13 2015 ... the addition of the "US & ... 16 Countries (2010-2021)" report to their ... announced the addition of the "US ... - 16 Countries (2010-2021)" report to ...
(Date:10/13/2015)... 13, 2015 anesthesia and respiratory ... billion by 2022, according to a new report by ... to their capability to resolve various environmental and lifestyle ... growth. --> anesthesia and respiratory devices market ... 2022, according to a new report by Grand View ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... ... Scientists in Seattle and Vancouver compared the diagnostic value of lung fluid cytology ... has just posted an article on the new research. Click here to read ... of British Columbia found that certain genetic alterations were seen just as often in ...
(Date:10/13/2015)... ... October 13, 2015 , ... Tempe Dental Care, a leading Tempe ... and IV sedation dentistry for more than 5 years. A leading cause ... serious and painful if treatment is not timely. , Sedation dentistry ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... Local Gold’s ... Gold’s Gym International Conference on August 26. Berry, who owns and operates Gold's ... for the fastest growing Gold’s Gyms in the United States. A brand leader in ...
(Date:10/13/2015)... ... October 13, 2015 , ... Thermi, an ... newest professional to introduce the latest development, ThermiVa® temperature controlled radiofrequency to the ... professional in Obstetrics and Gynecology and a pioneer in the field of laparoscopy. ...
(Date:10/13/2015)... ... October 13, 2015 , ... In an ongoing effort ... , a Southlake, Texas, child development and pediatric therapy center, is working with ... families about their options for receiving this kind of care for affected children. ...
Breaking Medicine News(10 mins):